Hsinchu, Taiwan

Chen-Ying Hung

This inventor holds 1 USPTO granted patent. Top assignee: Synbio Tech Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chen-Ying Hung. Retrieved from https://idiyas.com/inventor/chen-ying-hung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Chen-Ying Hung

Introduction

Chen-Ying Hung is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of innovative microbial strains. His work focuses on addressing health issues related to elevated levels of trimethylamine (TMA) and trimethylamine-n-oxide (TMAO).

Latest Patents

Chen-Ying Hung holds a patent for the LAM1345 isolate, which is a unique strain deposited at Deutsche Sammlung von Mikroorganismen and Zellkulturen GmbH under the accession number DSM 33510. This patent discloses a composition that includes the isolated strain of LAM1345, aimed at reducing TMA and TMAO levels in subjects. The application of this strain is particularly relevant for treating diseases associated with elevated TMA and TMAO levels.

Career Highlights

Currently, Chen-Ying Hung is employed at Synbio Tech Inc., where he continues to advance his research in synthetic biology and microbial applications. His innovative approach has positioned him as a key figure in the development of solutions for health-related challenges.

Collaborations

Chen-Ying Hung collaborates with esteemed colleagues such as San-Land Young and Hau-Yang Tsen, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

In summary, Chen-Ying Hung's contributions to biotechnology through his patent and work at Synbio Tech Inc. highlight his commitment to addressing critical health issues. His innovative research continues to pave the way for advancements in microbial applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…